Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Post by Sniper007on Apr 28, 2022 8:36pm
259 Views
Post# 34640843

Collaboration with Jansen

Collaboration with JansenCollaboration with Jansen (see link below if it works).

Google Bioaf: Collaboration arrangement with Jansen

"Alternatives that may be pursued include potential accretive merger or acquisition opportunities and future financings."

I talked with IR this week and things do seem to be going very, very, well (Psst - Frt, beenthere, Aarcor, maybe you should do the same). Accretive was definitely a word that was used multiple times. 

Acquisition opportunities scare me at this point in the game given that Bioasis has not yet accomplished anything truly worthy of a sp increase. I would like to hear others thoughts on this report released on tuesday from Zacks.

https://finance.yahoo.com/news/bioaf-collaboration-arrangement-janssen-101500677.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAACef_aMS7lyO4tGhnjmLyGWeNmvV7B0QZEV_p_Rm1k8s9KDdRPj0ZOfLrAumDjDWmsD7UUSgsC0tDxV8qFTJTqZYbwZ4kWPREsS5fgy_HmFlQmjR-z9jdv56jBZ6YAlGNVlEw0OjIWuT1YfofZtPLtsF5ivBX5jWTQ8bzdPGdRJI#:~:text=On%20April%2011th%2C%20Bioasis,develop%20and%20commercialize%20new%20products.
<< Previous
Bullboard Posts
Next >>